Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1425 of 3284 entries
View as:

Treatment and Exacerbation in COPD Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03375450 Org: User:
Start: 06/09/17 End: 08/30/19 Due: 08/30/20

Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00929708 Org: User:
Start: 06/30/09 End: 03/31/10 Due: 03/31/11

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Phase: N/A Priority: Normal
NCT ID: NCT00536965 Org: User:
Start: 07/31/07 End: 12/31/07 Due: 12/31/08

Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03927157 Org: User:
Start: 06/14/19 End: 08/13/24 Due: 08/13/25

AZD6765 for Treatment Resistant Depression

Phase: N/A Priority: Normal
NCT ID: NCT00491686 Org: User:
Start: 07/31/07 End: 11/30/07 Due: 11/30/08

Casodex vs Placebo in Non-Metastatic Early Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00672282 Org: User:
Start: 10/31/95 End: 08/31/08 Due: 08/31/09

GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin

Phase: N/A Priority: Normal
NCT ID: NCT00242372 Org: User:
Start: 08/31/04 End: 03/31/06 Due: 03/31/07

Phase I Study to Assess Absorption, Metabolism & Excretion of a Single Oral Dose [14C]AZD0530 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00853983 Org: User:
Start: 03/31/09 End: 04/30/09 Due: 04/30/10

The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics

Phase: N/A Priority: Normal
NCT ID: NCT00986531 Org: User:
Start: 11/30/09 End: 10/31/11 Due: 10/31/12

Quality Of Life While Receiving Faslodex

Phase: N/A Priority: Normal
NCT ID: NCT00643513 Org: User:
Start: 06/30/07 End: 01/31/09 Due: 01/31/10

Fast Titration in the Treatment of Schizophrenia, Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT00304473 Org: User:
Start: 08/31/04 End: 04/30/06 Due: 04/30/07

Quetiapine Fumarate Immediate Release (IR) Versus Extended Release (XR) Dose Escalation Comparison

Phase: N/A Priority: Normal
NCT ID: NCT00702676 Org: User:
Start: 07/31/08 End: 08/31/08 Due: 08/31/09

Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.

Phase: N/A Priority: Normal
NCT ID: NCT00786773 Org: User:
Start: 10/31/08 End: 06/30/09 Due: 06/30/10

A Study to Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02934607 Org: User:
Start: 11/04/16 End: 03/27/17 Due: 03/27/18

Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1940

Phase: N/A Priority: Normal
NCT ID: NCT00659490 Org: User:
Start: 02/29/08 End: 05/31/08 Due: 05/31/09

Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01119768 Org: User:
Start: 04/30/10 End: 06/30/11 Due: 06/30/12

Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02546661 Org: User:
Start: 12/28/16 End: 01/09/26 Due: 01/09/27

Multicentre Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Male Patients

Phase: N/A Priority: Normal
NCT ID: NCT00922025 Org: User:
Start: 08/31/09 End: 12/31/10 Due: 12/31/11

Multiple-ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03435276 Org: User:
Start: 02/27/18 End: 06/13/18 Due: 06/13/19

A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia

Phase: N/A Priority: Normal
NCT ID: NCT04964557 Org: User:
Start: 07/07/21 End: 07/15/22 Due: 07/15/23

Study to Assess the Effect of Ticagrelor on Coronary Blood Flow in Healthy Male Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT01226602 Org: User:
Start: 12/31/10 End: 04/30/11 Due: 04/30/12

AZD9164 Single Ascending Dose Study in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00847249 Org: User:
Start: 02/28/09 End: 04/30/09 Due: 04/30/10

A Two-part Single and Multiple Dose Study to Assess the Safety , Pharmacokinetics and Effects of AZD3293 in Healthy Japanese Young and Elderly Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02005211 Org: User:
Start: 12/31/13 End: 07/31/14 Due: 07/31/15

An Early Access Programme for Moxetumomab Pasudotox in Relapsed/Refractory Hairy Cell Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03501615 Org: User:
Start: - End: - Due: -

Efficacy and Safety of Twice Daily 60mg AZD9668 in COPD for 12 Weeks in Patients on Background Budesonide/Formoterol

Phase: N/A Priority: Normal
NCT ID: NCT01023516 Org: User:
Start: 11/30/09 End: 08/31/10 Due: 08/31/11